Wasman Jane is a director of Rigel Pharmaceuticals.
Person profile
Roles
Address
Ardsley, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
SELLAS Life Sciences Group, Inc.
25 Jan 24
4
RIGEL PHARMACEUTICALS INC
12 Jul 23
4
SELLAS Life Sciences Group, Inc.
3 Feb 23
4
ATHERSYS, INC / NEW
11 Jan 23
4
ATHERSYS, INC / NEW
20 Sep 22
4
RIGEL PHARMACEUTICALS INC
23 May 22
4
SELLAS Life Sciences Group, Inc.
1 Feb 22
4
ATHERSYS, INC / NEW
15 Jun 21
4
RIGEL PHARMACEUTICALS INC
21 May 21
4
SELLAS Life Sciences Group, Inc.
8 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jan 24 | SLS SELLAS Life Sciences | Common Stock | Grant | Acquire A | No | No | 0 | 6,000 | 0.00 | 10,400 |
22 Jan 24 | SLS SELLAS Life Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5195 | 10,000 | 5.20 k | 10,000 |
26 May 23 | RIGL Rigel Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 75,000 |
26 May 23 | RIGL Rigel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 30,000 | 39.60 k | 30,000 |
2 Feb 23 | SLS SELLAS Life Sciences | Common Stock | Grant | Acquire A | No | No | 0 | 2,500 | 0.00 | 4,400 |
2 Feb 23 | SLS SELLAS Life Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 3.34 | 9,500 | 31.73 k | 9,500 |
9 Jan 23 | ATHX Athersys, Inc / New | Common Stock | Grant | Acquire A | No | No | 0 | 22,321 | 0.00 | 35,141 |